|
Anexo 1: Características principales de la heterogeneidad alélica de
mutaciones en Adenomatous Polyposis Coli, Síndrome de Lynch
y Neoplasia asociada a colitis ulcerativa crónica inespecífica (CUCI).
|
|
|
FAP
|
AFAP/HFAS
|
HNPCC/Luynch
|
UCAN
|
|
Mean age at diagnosis
of colorectal cancer
|
32-39
|
45-55
|
42-49
|
40-70
|
|
Distribution of cancer
|
Random
|
Mainly
right colon
|
Mainly
right colon
|
Mainy
left colon
|
|
No of polyps
|
>100
|
1-100
|
1 (i.e. tumour)
|
|
|
Sex ratio (male:female)
|
1:1
|
1:1
|
1.5:1
|
1:1
|
|
Endoscopic view
of polyp
|
Pedunculated
|
Mainly flat
|
Pedunculated (45%);
flat (55%)
|
None
|
|
Lag time (years)
from early adenoma to
occurrence of cancer
|
10-20
|
10
|
5
|
?<8
|
|
Proportion (%)
of colonic cancer
|
1
|
0.5
|
1-5
|
<0.5
|
|
Superficial
physical stigmata
|
80% have retinal pigmentation None
|
None
|
Only in Muir-Torre syndrome
|
None
|
|
Distribution of polyps
|
Distal colon or universal
|
Main proximal to splenic with rectal sparing
|
Mainly proxicmal to splenic flexure
|
None
|
|
Carcinoma histology
|
More exophytic growth
|
Non-exophytic but very variable
|
Inflamation increased mucin
|
Mucosal ulceration and inflamation
|
|
Other
associated tumours
|
Duodenal
adenoma cerebral and thyroid tumours, medulloblastoma and desmoids
|
Duodenal adenoma
|
Endometrial ovarian, gastric cancer,
glioblastoma, many other cancers
|
|
|
Gene (chromosome)
mutation
|
APC (5q 21) distal to 5
|
APC (5q 21)
proximal to 5
|
MHS2 (2p), MLH1 (3p21), PMS1 (2q31), PMS2 (7p22)
|
Multiple mutations, 17p (p53), 5q (APC), 9p (p16)
|
|
FAP = familial adematosis polyposis coli; AFAP = attenuated familial adenomatous polyposis coli;
HFAS = hereditary flat adenoma syndrome; HNPPC = hereditary non-polyposis colon cancer;
UCAN = ulcerative colitis associated neoplasia.
Tomado de: Al-Sukhni W, Aronson M, Gallinger S. Hereditary colorectal cancer syndromes:
familial adenomatous polyposis and lynch syndrome.
Surg Clin North Am. 2008; 88: 819-844, vii. doi: 10.1016/j.suc.2008.04.012.
|